A biotechnology company awarded an STTR grant from the National Cancer Institute; non-dilutive federal funding will support preclinical and clinical work validating red blood cell-bound tumor DNA as an early detection biomarker for non-small cell lung cancer.
Dr. Nilam Mangalmurti
Scientific Co-founder and Chief Scientific Advisor
Neha Shah
Co-founder and CEO